Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report()

• 44 year old woman treated with bevacizumab for metastatic epithelial ovarian cancer; • The patient experienced vaginal cuff dehiscence and evisceration at 8 months post-operatively. • Metastasis at the surgical site and chronic inflammation implicated.

Detalles Bibliográficos
Autores principales: Skwara, Amanda J., Schilder, Russell J., Zibelli, Allison, Rosenblum, Norman G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862313/
https://www.ncbi.nlm.nih.gov/pubmed/24371706
http://dx.doi.org/10.1016/j.gynor.2013.06.005
_version_ 1782295732891418624
author Skwara, Amanda J.
Schilder, Russell J.
Zibelli, Allison
Rosenblum, Norman G.
author_facet Skwara, Amanda J.
Schilder, Russell J.
Zibelli, Allison
Rosenblum, Norman G.
author_sort Skwara, Amanda J.
collection PubMed
description • 44 year old woman treated with bevacizumab for metastatic epithelial ovarian cancer; • The patient experienced vaginal cuff dehiscence and evisceration at 8 months post-operatively. • Metastasis at the surgical site and chronic inflammation implicated.
format Online
Article
Text
id pubmed-3862313
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-38623132013-12-26 Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report() Skwara, Amanda J. Schilder, Russell J. Zibelli, Allison Rosenblum, Norman G. Gynecol Oncol Case Rep Case Report • 44 year old woman treated with bevacizumab for metastatic epithelial ovarian cancer; • The patient experienced vaginal cuff dehiscence and evisceration at 8 months post-operatively. • Metastasis at the surgical site and chronic inflammation implicated. Elsevier 2013-07-01 /pmc/articles/PMC3862313/ /pubmed/24371706 http://dx.doi.org/10.1016/j.gynor.2013.06.005 Text en © 2013 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Case Report
Skwara, Amanda J.
Schilder, Russell J.
Zibelli, Allison
Rosenblum, Norman G.
Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report()
title Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report()
title_full Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report()
title_fullStr Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report()
title_full_unstemmed Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report()
title_short Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report()
title_sort influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: a case report()
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862313/
https://www.ncbi.nlm.nih.gov/pubmed/24371706
http://dx.doi.org/10.1016/j.gynor.2013.06.005
work_keys_str_mv AT skwaraamandaj influenceofbevacizumabonvaginalcuffeviscerationeightmonthsafterovariancancercytoreductionsurgeryacasereport
AT schilderrussellj influenceofbevacizumabonvaginalcuffeviscerationeightmonthsafterovariancancercytoreductionsurgeryacasereport
AT zibelliallison influenceofbevacizumabonvaginalcuffeviscerationeightmonthsafterovariancancercytoreductionsurgeryacasereport
AT rosenblumnormang influenceofbevacizumabonvaginalcuffeviscerationeightmonthsafterovariancancercytoreductionsurgeryacasereport

Ejemplares similares